Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.3763
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST

Skinvisible Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
220010
Market Cap Growth
163.61%371.26%-17.16%-57.89%269.38%11.95%
Enterprise Value
887443
Last Close Price
0.380.340.080.100.240.07
PS Ratio
101.6689.5919.011.641.641.07
PB Ratio
-0.20-0.19-0.04-0.07-0.20-0.07
P/FCF Ratio
---10.162.916.45
P/OCF Ratio
---10.162.916.45
EV/Sales Ratio
-400.42325.7913.906.2010.46
EV/EBITDA Ratio
----19.95-
EV/EBIT Ratio
----21.85-
EV/FCF Ratio
---85.9510.9762.96
Debt / Equity Ratio
-0.58-0.62-0.68-0.56-0.57-0.62
Debt / EBITDA Ratio
----14.96-
Debt / FCF Ratio
---82.278.2360.32
Asset Turnover
0.140.130.101.183.101.44
Quick Ratio
0.010.010.010.030.020.02
Current Ratio
0.010.010.010.030.020.02
Return on Assets (ROA)
-257.24%-229.53%-149.63%-62.87%54.99%-83.00%
Return on Capital Employed (ROCE)
12.50%16.70%14.60%7.00%-6.60%10.10%
Earnings Yield
-24.14%-31.57%-626.61%-266.87%-98.42%-490.57%
FCF Yield
--3.90%-20.29%9.84%34.37%15.51%
Buyback Yield / Dilution
-25.54%-11.49%---1.06%-55.09%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.